|
|
Blood, 15 February 2004, Vol. 103, No. 4, pp. 1376-1382.
Prepublished online as a Blood First Edition Paper on October 30, 2003; DOI 10.1182/blood-2003-05-1748.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation
Annalisa Chiocchetti,
Manuela Indelicato,
Thea Bensi,
Riccardo Mesturini,
Mara Giordano,
Selina Sametti,
Luca Castelli,
Flavia Bottarel,
Maria Clorinda Mazzarino,
Letizia Garbarini,
Francesca Giacopelli,
Guido Valesini,
Claudio Santoro,
Irma Dianzani,
Ugo Ramenghi, and
Umberto Dianzani
From the Interdisciplinary Research Center of Autoimmune Diseases (IRCAD) and Department of Medical Science, "A. Avogadro" University of Eastern Piedmont, Novara, Italy; Department of Biomedical Sciences, University of Catania, Catania, Italy; Department of Pediatrics, University of Turin, Turin, Italy; G. Gaslini Institute and Department of Pediatrics and Center for Biomedical Research (CEBR), University of Genoa, Genoa, Italy; and Department of Medical Therapy, Division of Rheumatology, "La Sapienza" University of Rome, Rome, Italy.
The autoimmune/lymphoproliferative syndrome (ALPS) displays defective function of Fas, autoimmunities, lymphadenopathy/splenomegaly, and expansion of CD4/CD8 double-negative (DN) T cells. Dianzani autoimmune/lymphoproliferative disease (DALD) is an ALPS variant lacking DN cells. Both forms have been ascribed to inherited mutations hitting the Fas system but other factors may be involved. A pilot cDNA array analysis on a DALD patient detected overexpression of the cytokine osteopontin (OPN). This observation was confirmed by enzyme-linked immunosorbent assay (ELISA) detection of higher OPN serum levels in DALD patients (n = 25) than in controls (n = 50). Analysis of the OPN cDNA identified 4 polymorphisms forming 3 haplotypes (A, B, and C). Their overall distribution and genotypic combinations were different in patients (N = 26) and controls (N = 158) (P < .01). Subjects carrying haplotype B and/or C had an 8-fold higher risk of developing DALD than haplotype A homozygotes. Several data suggest that these haplotypes influence OPN levels: (1) in DALD families, high levels cosegregated with haplotype B or C; (2) in healthy controls, haplotype B or C carriers displayed higher levels than haplotype A homozygotes; and (3) in AB and AC heterozygotes, mRNA for haplotype B or C was more abundant than that for haplotype A. In vitro, exogenous OPN decreased activation-induced T-cell death, which suggests that high OPN levels are involved in the apoptosis defect.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
H. D. Shin, B. L. Park, H. S. Cheong, J.-H. Yoon, Y. J. Kim, and H.-S. Lee
SPP1 polymorphisms associated with HBV clearance and HCC occurrence
Int. J. Epidemiol.,
October 1, 2007;
36(5):
1001 - 1008.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Shaheen and N. L. Weintraub
Osteopontin: A Bona Fide Mediator of Abdominal Aortic Aneurysm?
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2007;
27(3):
439 - 441.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Golledge, J. Muller, N. Shephard, P. Clancy, L. Smallwood, C. Moran, A. E. Dear, L. J. Palmer, and P. E. Norman
Association Between Osteopontin and Human Abdominal Aortic Aneurysm
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2007;
27(3):
655 - 660.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Clementi, A. Chiocchetti, G. Cappellano, E. Cerutti, M. Ferretti, E. Orilieri, I. Dianzani, M. Ferrarini, M. Bregni, C. Danesino, et al.
Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective Fas function
Blood,
November 1, 2006;
108(9):
3079 - 3084.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Larkin, G. J. Renukaradhya, V. Sriram, W. Du, J. Gervay-Hague, and R. R. Brutkiewicz
CD44 Differentially Activates Mouse NK T Cells and Conventional T Cells
J. Immunol.,
July 1, 2006;
177(1):
268 - 279.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R Marciano, F Giacopelli, M T Divizia, M Gattorno, E Felici, A Pistorio, A Martini, R Ravazzolo, and P Picco
A polymorphic variant inside the osteopontin gene shows association with disease course in oligoarticular juvenile idiopathic arthritis
Ann Rheum Dis,
May 1, 2006;
65(5):
662 - 665.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Abel, S. Freigang, M. F. Bachmann, U. Boschert, and M. Kopf
Osteopontin Is Not Required for the Development of Th1 Responses and Viral Immunity
J. Immunol.,
November 1, 2005;
175(9):
6006 - 6013.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. K. Wong, L. C. W. Lit, L. S. Tam, E. K. Li, and C. W. K. Lam
Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus
Rheumatology,
May 1, 2005;
44(5):
602 - 606.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Kawamura, K. Iyonaga, H. Ichiyasu, J. Nagano, M. Suga, and Y. Sasaki
Differentiation, Maturation, and Survival of Dendritic Cells by Osteopontin Regulation
Clin. Vaccine Immunol.,
January 1, 2005;
12(1):
206 - 212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Giacopelli, R. Marciano, A. Pistorio, P. Catarsi, S. Canini, G. Karsenty, and R. Ravazzolo
Polymorphisms in the osteopontin promoter affect its transcriptional activity
Physiol Genomics,
December 15, 2004;
20(1):
87 - 96.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
